NCT03844685View on ClinicalTrials.gov

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 5, 2012

Primary Completion Date

March 25, 2014

Study Completion Date

February 23, 2016

Conditions
Breast Cancer
Interventions
DRUG

Promensil

1 tablet (80 mg) /day of MCE-11 (Promensil) taken orally for 24 months

DRUG

Placebo Oral Tablet

Placebo tablet (80 mg) (without active principle) given once a day for 24 months

Trial Locations (1)

20133

Cristina Ferraris, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT03844685 - Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen | Biotech Hunter | Biotech Hunter